Skip to main content

Inovio Pharma(INO-Q)
NASDAQ

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time

Latest News

Inovio Pharmaceuticals (INO) Q4 2023 Earnings Call Transcript
Motley Fool - Wed Mar 6, 10:30PM CST
Motley Fool
Wed Mar 6, 10:30PM CST
INO earnings call for the period ending December 31, 2023.
Inovio Pharmaceuticals (INO) Q3 2023 Earnings Call Transcript
Motley Fool - Thu Nov 9, 2023
Motley Fool
Thu Nov 9, 2023
INO earnings call for the period ending September 30, 2023.
INOVIO Announces U.S. FDA Breakthrough Therapy Designation Granted for INO-3107 for the Treatment of Recurrent Respiratory Papillomatosis
PR Newswire - Thu Sep 7, 2023
PR Newswire
Thu Sep 7, 2023
/PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from...
Inovio Pharmaceuticals (INO) Q2 2023 Earnings Call Transcript
Motley Fool - Wed Aug 9, 2023
Motley Fool
Wed Aug 9, 2023
INO earnings call for the period ending June 30, 2023.
INOVIO Announces Second Quarter 2023 Financial Results and Provides Strategic Update
PR Newswire - Wed Aug 9, 2023
PR Newswire
Wed Aug 9, 2023
Preparing to initiate pivotal Phase 3 trial of INO-3107 in adult RRP patients in first quarter of 2024; INO-3107 received Orphan Drug Designation from European...
INOVIO Reports Inducement Grants Under Inducement Plan
PR Newswire - Fri Aug 4, 2023
PR Newswire
Fri Aug 4, 2023
/PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from...
INOVIO to Report Second Quarter 2023 Financial Results on August 9, 2023
PR Newswire - Wed Jul 26, 2023
PR Newswire
Wed Jul 26, 2023
/PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from...
INOVIO Announces Notice of Pendency and Proposed Settlement of Stockholder Derivative Actions
GlobeNewswire - Fri Jun 23, 2023
GlobeNewswire
Fri Jun 23, 2023
INOVIO to Present at the 2023 Jefferies Healthcare Conference
PR Newswire - Thu May 25, 2023
PR Newswire
Thu May 25, 2023
/PRNewswire/ -- INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from...
INOVIO Announces Orphan Drug Designation for INO-3107 for the Treatment of Recurrent Respiratory Papillomatosis from the European Commission
PR Newswire - Tue May 23, 2023
PR Newswire
Tue May 23, 2023
/PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from...
Inovio Pharmaceuticals (INO) Q1 2023 Earnings Call Transcript
Motley Fool - Thu May 11, 2023
Motley Fool
Thu May 11, 2023
INO earnings call for the period ending March 31, 2023.
INOVIO Reports First Quarter 2023 Financial Results and Operational Highlights
PR Newswire - Wed May 10, 2023
PR Newswire
Wed May 10, 2023
Announced additional positive data from Phase 1/2 trial for INO-3107 in recurrent respiratory papillomatosis patients Second cohort of trial showed 10 of the...
INOVIO to Present at the 2023 RBC Capital Markets Global Healthcare Conference
PR Newswire - Fri May 5, 2023
PR Newswire
Fri May 5, 2023
/PRNewswire/ -- INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from...
INOVIO to Report First Quarter 2023 Financial Results on May 10, 2023
PR Newswire - Fri Apr 28, 2023
PR Newswire
Fri Apr 28, 2023
/PRNewswire/ -- INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from...
These 3 Nasdaq Stocks Are on Fire Today: Here's Why
Motley Fool - Mon Apr 17, 2023
Motley Fool
Mon Apr 17, 2023
A high-dollar buyout is lighting a fire underneath these three Nasdaq stocks today.
Why Inovio Pharmaceuticals' Shares Jumped on Thursday
Motley Fool - Thu Apr 13, 2023
Motley Fool
Thu Apr 13, 2023
The company will present an abstract for its Ebola vaccine booster this month.
INOVIO Announces Acceptance of Abstract for Oral Presentation on INO-4201 as an Ebola Booster for rVSV-ZEBOV (Ervebo®) at ECCMID 2023
PR Newswire - Wed Apr 12, 2023
PR Newswire
Wed Apr 12, 2023
/PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from...
Why Shares of Inovio Pharmaceuticals Were Down Tuesday
Motley Fool - Tue Apr 4, 2023
Motley Fool
Tue Apr 4, 2023
The biotech stock, still reeling from a failed clinical trial, hit a 52-week low.
INOVIO Reports Inducement Grant Under Inducement Plan
PR Newswire - Mon Apr 3, 2023
PR Newswire
Mon Apr 3, 2023
/PRNewswire/ -- INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from...
INOVIO to Present at the Oppenheimer 33rd Annual Healthcare Conference
PR Newswire - Fri Mar 3, 2023
PR Newswire
Fri Mar 3, 2023
/PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from...
Inovio Pharmaceuticals (INO) Q4 2022 Earnings Call Transcript
Motley Fool - Wed Mar 1, 2023
Motley Fool
Wed Mar 1, 2023
INO earnings call for the period ending December 31, 2022.
INOVIO Reports Fourth Quarter and Full Year 2022 Financial Results and Clinical Highlights
PR Newswire - Wed Mar 1, 2023
PR Newswire
Wed Mar 1, 2023
Announces topline results from REVEAL2, the second Phase 3 trial evaluating VGX-3100 as a treatment for cervical high-grade squamous intraepithelial lesions...
2 Stocks to Sell or Remove From Your Watchlist in 2023
Motley Fool - Tue Feb 28, 2023
Motley Fool
Tue Feb 28, 2023
Both stocks soared during the coronavirus vaccine race, but their time has passed.
Coronavirus Vaccine Market To Surpass $95 Billion By 2028
PR Newswire - Tue Feb 28, 2023
PR Newswire
Tue Feb 28, 2023
/PRNewswire/ -- The Coronavirus Global Market has been growing in the past few years and is anticipated to continue to grow in the next several years. In fact,...
INOVIO Reports Inducement Grants Under Inducement Plan
PR Newswire - Fri Feb 3, 2023
PR Newswire
Fri Feb 3, 2023
/PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from...